NLRP3 and COVID-19: TLR7 stimulation may induce IFN-regulated cytokines release and, interestingly, SARS-CoV-2, binding the TLR, may promote NLRP3 inflammasome activation (Conti et al., 2020), further inducing an inflammatory response and worsening the prognosis of COVID-19.